Well Referenced

Tag: Urology

Availability of platelet-rich plasma for treatment of erectile dysfunction and associated costs and efficacy: A review of current publications and Canadian data

This 2021 review assessed the availability, cost, and clinical evidence of platelet-rich plasma (PRP) therapy for erectile dysfunction (ED) in Canada. The authors identified 19 Canadian providers offering PRP injections for ED, with an average cost of $1,777 CAD per injection. None of these providers were affiliated with academic institutions,

Read More »
June 26, 2025 No Comments

The Cost of Prostate Biopsies and their Complications: A Summary of Data on All Medicare Fee-for-Service Patients over 2 Years

This 2020 retrospective study analyzed 234,819 prostate biopsy episodes among Medicare fee-for-service patients between January 2014 and December 2015. The average cost per biopsy episode was $2,020, with nearly half of the costs (46%) incurred in the 30 days following the procedure. Biopsies performed in office settings were less expensive

Read More »
June 26, 2025 No Comments

Extracorporeal Shock Wave Therapy (ESWT) in Urology: A Systematic Review of Outcome in Peyronie’s Disease, Erectile Dysfunction and Chronic Pelvic Pain

In this 2017 systematic review, Fojecki et al. evaluated the efficacy of extracorporeal shock wave therapy (ESWT) in treating Peyronie’s disease (PD), erectile dysfunction (ED), and chronic pelvic pain syndrome (CPPS). The authors analyzed multiple randomized controlled trials and observational studies to assess the outcomes of ESWT on these urological

Read More »
June 26, 2025 No Comments

Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study

In this rigorously designed double-blind, randomized, placebo-controlled trial, Yee et al. evaluated the efficacy of low-intensity extracorporeal shockwave therapy (Li-ESWT) in men with mild to moderate vasculogenic erectile dysfunction (ED). The study enrolled 60 participants, randomly assigned to receive either Li-ESWT or a sham procedure over a 9-week period. The

Read More »
June 26, 2025 No Comments

Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie’s disease using two different electromagnetic lithotripters

In this retrospective study, Rassweiler et al. evaluated the long-term efficacy of high-energy shock wave therapy (HESWT) in managing chronic-phase Peyronie’s disease (PD) using two different electromagnetic lithotripters. The study included 82 patients treated between 1999 and 2008, divided into two groups based on the lithotripter used: the Modulith SLX

Read More »
June 26, 2025 No Comments

Does Low Intensity Extracorporeal Shock Wave Therapy Have a Physiological Effect on Erectile Function? Short-term Results of a Randomized, Double-Blind, Sham Controlled Study

In this 2012 randomized, double-blind, sham-controlled trial, Vardi et al. investigated the physiological effects of low-intensity extracorporeal shock wave therapy (Li-ESWT) on erectile function in men with vasculogenic erectile dysfunction (ED). The study enrolled 20 men who were randomized to receive either Li-ESWT or a sham procedure over a 9-week

Read More »
June 26, 2025 No Comments

Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis

In this 2017 systematic review and meta-analysis, Clavijo et al. assessed the efficacy of low-intensity extracorporeal shockwave therapy (Li-ESWT) for treating erectile dysfunction (ED). The analysis included seven randomized controlled trials encompassing 602 men with vasculogenic ED. The primary outcome measured was the change in the International Index of Erectile

Read More »
June 26, 2025 No Comments

Stable Gastric Pentadecapeptide BPC 157 Heals Rat Colovesical Fistula

This preclinical study evaluated the therapeutic effects of BPC 157, a stable gastric pentadecapeptide, on healing colovesical fistulas in rats. Wistar Albino male rats with surgically induced colovesical fistulas were treated with BPC 157 administered either intraperitoneally or orally. The treatment led to accelerated fistula closure, reduced inflammation, and improved

Read More »
June 26, 2025 No Comments

Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health

This prospective study assessed the relationship between body mass index (BMI), urinary incontinence (UI), and female sexual dysfunction (FSD) among perimenopausal and postmenopausal women. From 2005 to 2008, 208 women with UI were enrolled; 158 completed both the Urogenital Distress Inventory and the Female Sexual Function Index (FSFI). Participants were

Read More »
June 26, 2025 No Comments